Skip to content

A study on people with schizophrenia to find and study the occurrence of obsessions and compulsive behaviour

Co-occurrence of Obsessive compulsive symptoms in patients with schizophrenia and comparison of clinical profile, cognitive and socio-occupational functioning in those with and without Obsessive compulsive symptoms : a cross sectional tertiary hospital based study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/074577
Enrollment
89
Registered
2024-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

PG Research Fund, KMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosis of schizophrenia (according to DSM-5) 2) Age group : 18 – 60 years 3) Patients consenting to take part in the study 4) Who are able to understand English/ Kannada and identify English numbers

Exclusion criteria

Exclusion criteria: 1) Presence of comorbid neurological condition like stroke, epilepsy, degenerative diseases, Movement disorder etc. 2) Uncontrolled chronic medical conditions like hypertension, diabetes, hypothyroidism 3) Intellectual disability 4) Presence of substance use – except nicotine 5) Comorbid other psychiatry conditions such as Mood Disorder, Personality disorder. 6) History of head injury 7) Autoimmune conditions

Design outcomes

Primary

MeasureTime frame
a)Presence of OC symptoms/OCD in patients with schizophrenia. b)Sociodemographic and clinical variables associated with OC symptoms in Schizophrenia. c)To compare socio-occupational functioning in people having schizophrenia with and without OCD or OC symptoms. d)Based on study conducted by Punya Mulky et al.2015 having a sample size of 100 and prevalence of 28%, the sample size estimated for study is 89. Timepoint: At a single time point.Will be assessed at end of the study

Secondary

MeasureTime frame
Association of antipsychotic used with OC symptomsTimepoint: At a single time point.Will be assessed at end of the study

Countries

India

Contacts

Public ContactDr Rajeshkrishna Bhandary

KMC, Manipal

rajesh.kbp@manipal.edu9844542567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026